Home›Stock Screener›Global Health›Financial Statements

Global Health Complete Financial Statements

11 Years of Data
2026 - 2015

In FY2026, Global Health (MEDANTA) reported revenue ₹1,196 Cr, net profit ₹142 Cr and EPS ₹5.36, with a net profit margin of 11.9% and ROE of 3.6%. Full financial statements from FY2015 to FY2026 (11 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse MEDANTA shareholder distribution to track promoter, FII and institutional holdings.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 11.87% 2026 data
EBITDA Margin 23.49% 2026 data
Operating Margin 21.00% 2026 data
Return on Assets 2.40% 2026 data
Return on Equity 3.58% 2026 data

Balance Sheet Ratios

Current Ratio 1.29 2026 data
Equity Ratio 67.10% 2026 data
Asset Turnover 0.20 2026 data

MEDANTA Revenue, Net Profit & EBITDA — Year-on-Year Growth

MEDANTA YoY (Mar 2025 vs Mar 2026) — revenue +25.4%, net profit +40.6%, EBITDA +41.9%, expenses +20.9%. For live price, earnings ratios and company overview, see MEDANTA screener.

Revenue Growth
+25.4%
Year-over-Year
Net Profit Growth
+40.6%
Year-over-Year
EBITDA Growth
+41.9%
Year-over-Year
Expense Growth
+20.9%
Year-over-Year
Assets Growth
+23.9%
Year-over-Year
Equity Growth
+16.9%
Year-over-Year
Operating Cash Flow Growth
+2.0%
Year-over-Year
Investing Cash Flow Growth
-63.5%
Year-over-Year
Financing Cash Flow Growth
+81.1%
Year-over-Year

MEDANTA Income Statement — Revenue, EBITDA & Net Profit

Global Health revenue ₹1,196 Cr, EBITDA ₹281 Cr, net profit ₹142 Cr, EPS ₹5.36 (2026) — net profit margin 11.9%. Examine MEDANTA quarterly performance for recent quarterly revenue, profit and EPS trends.

Periods ₹ Crores
Particulars Mar 2026 Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Jun 2021 Dec 2021
Revenue 1,196 1,135 954 1,051 1,143 975 836 883 960 865 732 795 855 695 533 627 706 588 492 593
Expenses 915 868 757 784 940 728 629 675 706 631 540 595 621 523 441 485 534 442 386 448
EBITDA 281 267 198 267 203 247 207 208 254 234 192 199 234 172 92 142 172 146 106 146
Operating Profit Margin % 21.00% 21.00% 19.00% 24.00% 16.00% 24.00% 22.00% 22.00% 25.00% 25.00% 24.00% 24.00% 26.00% 23.00% 15.00% 21.00% 23.00% 24.00% 21.00% 23.00%
Depreciation 67 50 49 45 61 49 46 47 49 43 38 40 44 37 35 36 39 31 31 33
Interest 27 17 15 14 22 16 18 18 16 20 21 18 18 18 28 19 21 17 16 18
Profit Before Tax 187 200 133 208 120 181 143 144 189 171 133 141 172 117 29 87 112 98 58 95
Tax 46 41 32 49 25 50 16 37 46 45 32 39 49 31 12 28 32 31 16 25
Net Profit 142 158 101 159 95 131 127 106 143 125 101 102 124 86 18 59 81 67 42 70
Earnings Per Share (₹) 5.36 5.89 3.77 5.92 3.54 4.87 4.74 3.96 5.32 4.66 3.77 3.80 4.61 3.38 0.69 2.32 3.08 13.22 5.13 2.76

MEDANTA Balance Sheet — Assets, Liabilities & Shareholders' Equity

MEDANTA total assets ₹5,905 Cr, total equity ₹3,962 Cr, total liabilities ₹ Cr (2026) — ROE 3.6%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 5,905 4,766 4,304 4,116 3,146 2,694 0 2,430 1,984
Current Assets 1,675 1,533 1,509 1,580 812 502 0 489 472
Fixed Assets 3,927 2,514 2,236 2,050 1,776 1,616 0 1,194 1,094
Capital Work in Progress 132 533 388 327 439 464 0 666 317
Investments 79 3 0 0 0 0 0 0 0
Other Assets 0 1,716 1,681 1,739 930 615 0 570 573
LIABILITIES
Total Liabilities
Current Liabilities 1,294 760 781 1,115 1,110 907 0 839 432
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 3,962 3,388 2,906 2,428 1,616 1,382 0 1,296 1,217
Share Capital 54 54 54 54 51 50 0 49 81
Reserves & Surplus 3,908 3,333 2,852 2,375 1,565 1,300 0 1,214 1,136

MEDANTA Cash Flow Statement — Operating, Investing & Financing

Global Health operating cash flow ₹624 Cr, investing ₹-721 Cr, financing ₹-97 Cr, net cash flow ₹-194 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2016 March 2015
Operating Activities 624 612 645 311 242 175 166 63 228 213
Investing Activities -721 -441 -342 -421 -239 -87 -249 -69 -241 -126
Financing Activities -97 -514 346 160 -81 -1 97 9 -7 -88
Net Cash Flow -194 -343 648 50 -78 87 14 3 -20 0